Core Viewpoint - Centene (CNC) is currently undervalued despite recent struggles, with potential upside linked to possible extensions of ACA insurance subsidies, which could positively impact its business model [1][4]. Company Overview - Centene is based in St. Louis and manages government-sponsored health insurance programs, including Medicaid, Medicare, and ACA plans [2]. - The current market capitalization of Centene is $19 billion, with a stock price of $39.32 [3]. Recent Performance - Centene's stock price has seen significant volatility, dropping from over $56 per share in July to below $26 in early August due to concerns over subsidy extensions and Medicaid cuts [5][6]. - The stock has rebounded nearly 19% over the past month, aided by better-than-expected earnings and revenue reports [7]. Market Influences - The stock's performance is closely tied to Medicare and Medicaid spending, as well as the status of ACA health plans [8]. - Recent reports suggest that President Trump may propose a two-year extension for ACA insurance subsidies, which could garner Republican support and benefit Centene as the largest provider in ACA marketplaces [4].